scholarly article | Q13442814 |
P50 | author | Marco Matucci-Cerinic | Q19859583 |
Eloisa Romano | Q92547424 | ||
Felice Galluccio | Q96024292 | ||
Riccardo Terenzi | Q114309912 | ||
Mirko Manetti | Q47143114 | ||
Lidia Ibba-Manneschi | Q47265756 | ||
Serena Guiducci | Q47265812 | ||
P2093 | author name string | Serena Guiducci | |
Irene Rosa | |||
P2860 | cites work | Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injury. | Q51140106 |
Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway. | Q53550461 | ||
A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis | Q68827906 | ||
Captopril: a new treatment for rheumatoid arthritis? | Q72580522 | ||
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study | Q77525064 | ||
Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis | Q78744711 | ||
Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis | Q79695004 | ||
Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis | Q80182570 | ||
Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis | Q82294472 | ||
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis | Q24598633 | ||
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 | ||
Angiotensin II in inflammation, immunity and rheumatoid arthritis | Q26991828 | ||
Angiotensin II type 2 receptor mediates programmed cell death | Q28272739 | ||
Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors | Q28364369 | ||
Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats | Q28571720 | ||
The pathogenesis of rheumatoid arthritis | Q29614957 | ||
A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes | Q30300953 | ||
Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction | Q30309594 | ||
The angiotensin II type 2 receptor and improved adjacent region function post-MI. | Q30436784 | ||
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation | Q33205413 | ||
Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells | Q33600747 | ||
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer | Q33792965 | ||
Expressions of local renin-angiotensin system components in chondrocytes | Q33851298 | ||
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
The AT2 receptor--a matter of love and hate | Q34436809 | ||
Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis | Q34731369 | ||
Role of the renin-angiotensin system in vascular inflammation | Q34789029 | ||
Protective effects of angiotensin II interruption: evidence for antiinflammatory actions | Q36257966 | ||
The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats | Q36404036 | ||
Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo | Q36546985 | ||
Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production | Q36981859 | ||
Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis | Q37557554 | ||
High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis | Q37775403 | ||
The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis. | Q38771740 | ||
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. | Q39900531 | ||
Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. | Q40562942 | ||
Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? | Q41206012 | ||
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis | Q42165744 | ||
Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR. | Q42528495 | ||
Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice | Q46689553 | ||
Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats | Q46884693 | ||
Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression | Q48350568 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 13293 | |
P577 | publication date | 2017-10-16 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium | |
P478 | volume | 7 |
Q90305559 | Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism |
Q58732246 | Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion |
Q51737917 | Morphological evidence of telocytes in human synovium. |
Q97074100 | Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS |
Q108591796 | Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID |
Search more.